Your search returned 3 results.

Results
	1.	New challenges for HDL-modifying therapies as a strategy to lower cardiovascular disease events in statin-treated patients. MedStar authors: Brewer, H Bryan Jr PMID: 25702643 Year: 2015 Citation: Cardiovascular Drugs & Therapy. 29(1):1-3, 2015 Feb. Institution: MedStar Heart & Vascular Institute Medline publication type: Comment Editorial Form of publication: Journal Article All authors: Brewer HB Jr, Rosenson RS DOI: http://dx.doi.org/10.1007/s10557-015-6576-7 Add to cart (remove)
	2.	Dysfunctional HDL and atherosclerotic cardiovascular disease. [Review] MedStar authors: Brewer, H Bryan PMID: 26323267 Year: 2016 Citation: Nature Reviews Cardiology. 13(1):48-60, 2016 Jan. Institution: MedStar Health Research Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Ansell BJ, Barter P, Brewer HB Jr, Chapman MJ, Heinecke JW, Kontush A, Rosenson RS, Tall AR, Webb NR DOI: http://dx.doi.org/10.1038/nrcardio.2015.124 Add to cart (remove)
	3.	Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib. MedStar authors: Brewer, H Bryan PMID: 26564598 Year: 2015 Citation: Journal of the American College of Cardiology. 66(20):2201-10, 2015 Nov 17. Institution: MedStar Health Research Institute Medline publication type: Clinical Trial, Phase II Journal Article Multicenter Study Randomized Controlled Trial Form of publication: Journal Article All authors: Adelman SJ, Brewer HB, Kane JP, Krueger KA, Nicholls SJ, Nissen SE, Rader DJ, Ruotolo G, Wang MD DOI: http://dx.doi.org/10.1016/j.jacc.2015.09.013 Add to cart (remove)

Powered by Koha